TG Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 25, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	4,336	4,320	2,416	1,584	2,488	6,703
Market Cap Growth	-15.82%	78.80%	52.51%	-36.33%	-62.88%	515.51%
Enterprise Value	4,506	4,233	2,297	1,491	2,159	6,490
Last Close Price	30.51	30.10	17.08	11.83	19.00	52.02
PE Ratio	10.68	184.75	190.66	-	-	-
Forward PE	21.04	45.21	-	-	-	-
PS Ratio	8.24	13.13	10.34	568.84	371.96	44096.70
PB Ratio	7.17	19.43	15.05	27.04	10.49	12.91
P/TBV Ratio	7.22	19.43	15.05	27.41	10.53	12.93
EV/Sales Ratio	8.47	12.87	9.83	535.24	322.82	42698.06
EV/EBITDA Ratio	43.82	100.79	110.20	-	-	-
EV/EBIT Ratio	43.84	100.95	111.33	-	-	-
Debt / Equity Ratio	0.42	1.14	0.69	1.42	0.34	0.08
Debt / EBITDA Ratio	2.43	5.74	4.82	-	-	-
Net Debt / Equity Ratio	0.20	-0.25	-0.66	-1.34	-0.99	-1.08
Net Debt / EBITDA Ratio	1.20	-1.35	-5.10	0.36	0.68	2.06
Net Debt / FCF Ratio	-1.75	1.40	3.39	0.45	0.80	2.62
Asset Turnover	0.66	0.73	0.89	0.01	0.01	0
Inventory Turnover	0.67	0.51	-	-	-	-
Quick Ratio	2.53	4.85	5.00	3.04	4.84	6.92
Current Ratio	3.83	6.25	5.92	3.16	5.06	6.99
Return on Equity (ROE)	111.96%	12.21%	11.57%	-151.36%	-92.03%	-100.14%
Return on Assets (ROA)	7.98%	5.78%	4.93%	-47.61%	-42.87%	-43.36%
Return on Invested Capital (ROIC)	20.37%	34.84%	116.52%	-	-	-
Return on Capital Employed (ROCE)	11.80%	8.60%	7.50%	-155.50%	-109.70%	-50.80%
Earnings Yield	10.21%	0.54%	0.52%	-14.13%	-13.99%	-4.17%
FCF Yield	-1.60%	-0.94%	-1.30%	-11.12%	-11.90%	-3.21%
Buyback Yield / Dilution	-11.64%	-7.96%	-9.67%	-2.41%	-14.64%	-30.51%

Updated Nov 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q